Citations of this article
Mendeley users who have this article in their library.
Get full text


Angiotensin-converting enzyme inhibitors exert a beneficial effect on nephritis. We investigated the effects of KD3-671, an angiotensin AT1receptor antagonist (2-propyl-8-oxo-1-[(2'-(1 H-tetrazole-5-yl)biphenyl-4-yl)methyl]-4,5,5,7-tetrahydro-cycloheptimidazole), on anti-glomerular basement membrane antibody-associated nephritis in rats. Untreated nephritic rats had massive proteinuria, glomerular lesions including crescent formation, a significant augmentation of proliferating cell nuclear antigen-positive cells, α-smooth muscle actin-positive cells, and the increase in deposition of proteoglycan, fibronectin and desmin in the glomeruli. Administration of KD3-671 to nephritic rats prevented the development of intense proteinuria, glomerular alterations and the increase in plasma urea nitrogen. KD3-671 suppressed the deposition of matrix protein and the expression of α-smooth muscle actin and desmin in the nephritic glomeruli. Captopril, an angiotensin-converting enzyme inhibitor, suppressed urinary protein excretion and the expression of desmin in the nephritic glomeruli, but not other parameters. These results suggest that KD3-671 may be a useful medicine against glomerulonephritis and glomerulosclerosis.




Nagamatsu, T., Hayashi, K., Oka, T., & Suzuki, Y. (1999). Angiotensin II type I receptor antagonist suppresses proteinuria and glomerular lesions in experimental nephritis. European Journal of Pharmacology, 374(1), 93–101. https://doi.org/10.1016/S0014-2999(99)00276-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free